Detalles de la búsqueda
1.
177Lu-Dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1752-1763, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34793718
2.
Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors.
Anticancer Drugs
; 31(3): 216-222, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31977567
3.
Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Oncologist
; 24(4): 463-474, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355775
4.
Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review.
Oncology
; 96(6): 273-289, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31018209
5.
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.
Oncologist
; 23(1): 16-24, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038234
6.
LANREOTIDE THERAPY IN CARCINOID SYNDROME: PROSPECTIVE ANALYSIS OF PATIENT-REPORTED SYMPTOMS IN PATIENTS RESPONSIVE TO PRIOR OCTREOTIDE THERAPY AND PATIENTS NAÏVE TO SOMATOSTATIN ANALOGUE THERAPY IN THE ELECT PHASE 3 STUDY.
Endocr Pract
; 24(3): 243-255, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29547049
7.
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
N Engl J Med
; 371(3): 224-33, 2014 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25014687
8.
EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
Endocr Pract
; 22(9): 1068-80, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27214300
9.
Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations.
Oncologist
; 20(10): 1123-31, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26306904
10.
Pharmacokinetic study of aldoxorubicin in patients with solid tumors.
Invest New Drugs
; 33(2): 341-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25388939
11.
Everolimus for advanced pancreatic neuroendocrine tumors.
N Engl J Med
; 364(6): 514-23, 2011 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21306238
12.
Long-term everolimus treatment of patients with pancreatic neuroendocrine tumors.
Chemotherapy
; 60(3): 143-50, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25766415
13.
Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Pancreatology
; 13(3): 324-6, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23719609
14.
Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy.
Clin Adv Hematol Oncol
; 16 Suppl 17(9): 11-14, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30807563
15.
Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma.
Clin Adv Hematol Oncol
; 16 Suppl 17(9): 1-16, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30807558
16.
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
Lancet
; 378(9808): 2005-2012, 2011 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22119496
17.
Resection Prolongs Overall Survival for Nonmetastatic Midgut Small Bowel Neuroendocrine Tumors: A National Cancer Data Base Study.
Pancreas
; 51(2): 171-176, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35404893
18.
The Mount Sinai Clinical Pathway for the Diagnosis and Management of Hypercortisolism due to Ectopic ACTH Syndrome.
J Endocr Soc
; 6(7): bvac073, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35668997
19.
Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance).
Endocr Relat Cancer
; 29(6): 335-344, 2022 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324465
20.
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study.
Endocrine
; 71(2): 502-513, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33052555